MARKER THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$19M
↓-13.4% -$3Mvs FY2024
Total Liabilities
$2M
↓-34.4% -$1Mvs FY2024
Equity
$17M
↓-9.5% -$2Mvs FY2024
Cash
$16M
↓-16.3% -$3Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $19M | $22M |
| Current Assets | $19M | $22M |
| Cash | $16M | $19M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $3M | $3M |
| Non-Current Assets | $0 | $0 |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $0 | $0 |
| Total Liab+Eq | $19M | $22M |
| Current Liab. | $2M | $3M |
| Accounts Payable | $794K | $1M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $975K | $0 |
| Other CL | $506K | $2M |
| Non-Current Liab. | $0 | $0 |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $0 |
| Equity | $17M | $19M |
| Retained Earnings | $459M | $447M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · MRKR · Comparing FY2025 vs FY2024